Surgery for Stage III T4 NSCLC with Unresolved Lung Abscess

Rationale for Surgical Intervention

The American College of Surgeons and oncology experts recommend surgery as the treatment of choice for resectable T4N0-1 tumors, as favorable outcomes are consistently reported after extended resections, with complete resection offering the only curative option for this stage III NSCLC 1, 2

Complete resection must be technically achievable, as incomplete resection yields 5-year survival rates below 5%, and the surgical team should confirm this before proceeding 2
Nodal status must be N0 or N1, as the presence of N2 disease or N3 disease would shift treatment toward definitive chemoradiation rather than surgery, according to the National Comprehensive Cancer Network 3, 4
Cardiopulmonary fitness must be adequate, with formal lung function testing with FEV1 and DLCO assessment mandatory, and exercise testing recommended for borderline candidates, as suggested by the American Thoracic Society 1

Anatomical resection with complete mediastinal lymph node dissection is mandatory, as systematic nodal dissection or complete MLND should be performed to ensure accurate staging and maximize local control, according to the Society of Thoracic Surgeons 2

For stage III T4N0-1 disease, the optimal approach is induction chemotherapy followed by surgical resection, as recommended by the European Society for Medical Oncology 1, 3
Adjuvant chemotherapy can be administered postoperatively for completely resected stage III disease, as suggested by the National Cancer Institute 1, 3

5-year survival rates of 25-30% are achievable with complete resection and adjuvant therapy, according to the American Cancer Society 2
Perioperative mortality for lobectomy ranges from 2-8% depending on age and comorbidities, as reported by the Society of Thoracic Surgeons 5